Improved lung function and quality of life following guaifenesin treatment in a patient with chronic obstructive pulmonary disease (COPD): A case report

We report improved lung function and quality of life following daily use of guaifenesin/dextromethorphan (Mucinex DM(®), Reckitt Benckiser) for the treatment of mucus-related symptoms in a patient with COPD, who presented with increasing dyspnea, progressive cough and chest congestion.

Detalles Bibliográficos
Autores principales: Storms, William W., Miller, Judi E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010616/
https://www.ncbi.nlm.nih.gov/pubmed/29977767
http://dx.doi.org/10.1016/j.rmcr.2018.04.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010616/
https://www.ncbi.nlm.nih.gov/pubmed/29977767
http://dx.doi.org/10.1016/j.rmcr.2018.04.009

Ejemplares similares